TherapeuticsMD reported $20K in Interest Expense on Debt for its fiscal quarter ending in September of 2023.





Interest Expense On Debt Change Date
AbbVie USD 688M 58M Sep/2026
Cipla INR 167.4M 2.9M Sep/2026
Compugen USD 1.84M 485K Jun/2026
CSL USD 215M 111M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Pfizer USD 662M 5M Sep/2026
TherapeuticsMD USD 20K 25K Sep/2023